- Home
- Publications
- Publication Search
- Publication Details
Title
TERT Promoter Alterations in Glioblastoma: A Systematic Review
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 5, Pages 1147
Publisher
MDPI AG
Online
2021-03-09
DOI
10.3390/cancers13051147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival
- (2020) Han-wen Zhang et al. ACADEMIC RADIOLOGY
- Avoiding New Biopsies by Identification of IDH1 and TERT Promoter Mutation in Nondiagnostic Biopsies From Glioma Patients
- (2020) Marc Barritault et al. NEUROSURGERY
- Targeting telomerase for its advent in cancer therapeutics
- (2020) Shalini Bajaj et al. MEDICINAL RESEARCH REVIEWS
- Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI
- (2020) Hongan Tian et al. Biomed Research International
- A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
- (2020) Nayuta Higa et al. CANCER SCIENCE
- Anti-cancer Immunotherapies Targeting Telomerase
- (2020) Simone Negrini et al. Cancers
- New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma
- (2020) Tiziana Pierini et al. Acta Neuropathologica Communications
- Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities
- (2020) Santiago Haase et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
- (2020) Lisa Mayr et al. Journal of Personalized Medicine
- MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma
- (2019) Jana Ivanidze et al. JOURNAL OF NEUROIMAGING
- Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis
- (2019) Verena Körber et al. CANCER CELL
- Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts
- (2019) Masamichi Takahashi et al. CANCER SCIENCE
- Telomerase-Targeted Cancer Immunotherapy
- (2019) Eishiro Mizukoshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis
- (2019) Lindsey Lowder et al. JOURNAL OF NEURO-ONCOLOGY
- Predicting TERT promoter mutation using MR images in patients with wild-type IDH1 glioblastoma
- (2019) K. Yamashita et al. Diagnostic and Interventional Imaging
- TERTp mutation detection in plasma by droplet-digital PCR in spinal myxopapillary ependymoma with lung metastases.
- (2019) Anne Deniel et al. World Neurosurgery
- Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation
- (2019) Cheila Brito et al. BMC CANCER
- Identification of IDH and TERTp mutation status using 1 H‐MRS in 112 hemispheric diffuse gliomas
- (2019) Esin Ozturk‐Isik et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Survival of diffuse astrocytic glioma, IDH1/2-wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria
- (2019) C Mircea S Tesileanu et al. NEURO-ONCOLOGY
- Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
- (2019) Evangelia Razis et al. Translational Oncology
- TERT promoter mutation detection in cell-free tumor-derived DNA in patients withIDHwild-type glioblastomas - a pilot prospective study
- (2018) Tareq A. Juratli et al. CLINICAL CANCER RESEARCH
- Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells
- (2018) C. Lavanya et al. CYTOTECHNOLOGY
- Mutant ATRX: uncovering a new therapeutic target for glioma
- (2018) Santiago Haase et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas
- (2018) Hyun Sik Kim et al. PATHOLOGY RESEARCH AND PRACTICE
- The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival
- (2018) Chang Shu et al. Cancer Medicine
- cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
- (2018) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
- (2018) Andrew Mancini et al. CANCER CELL
- Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
- (2018) Yu Yao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies
- (2018) Cigir Biray Avci et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors
- (2018) Takahiro Sasaki et al. JOURNAL OF NEURO-ONCOLOGY
- Primary brain tumours in adults
- (2018) Sarah Lapointe et al. LANCET
- Human glioblastoma arises from subventricular zone cells with low-level driver mutations
- (2018) Joo Ho Lee et al. NATURE
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas
- (2018) Bill H Diplas et al. NEURO-ONCOLOGY
- Enhanced detection of circulating tumor DNA by fragment size analysis
- (2018) Florent Mouliere et al. Science Translational Medicine
- Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
- (2018) Nathalie E. Synhaeve et al. Acta Neuropathologica Communications
- Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management
- (2017) Dominik Sturm et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma
- (2017) Deborah R. Smith et al. JOURNAL OF NEURO-ONCOLOGY
- Systematic analysis of telomere length and somatic alterations in 31 cancer types
- (2017) Floris P Barthel et al. NATURE GENETICS
- Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
- (2017) Khalil Abou-El-Ardat et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma
- (2017) Tunc F. Ersoy et al. NEURORADIOLOGY
- Glioma Subclassifications and Their Clinical Significance
- (2017) Ricky Chen et al. Neurotherapeutics
- Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting
- (2017) Ekkehard Hewer et al. VIRCHOWS ARCHIV
- Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status
- (2017) Chiara Pesenti et al. Oncotarget
- The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
- (2017) Yujin Lee et al. Acta Neuropathologica Communications
- Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas
- (2017) Ralph Salloum et al. Acta Neuropathologica Communications
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel
- (2016) Angela Zacher et al. BRAIN PATHOLOGY
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients
- (2016) Y. Yao et al. CLINICAL CANCER RESEARCH
- The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
- (2016) Rui Batista et al. INTERNATIONAL JOURNAL OF CANCER
- TERT mutation in glioma: Frequency, prognosis and risk
- (2016) Yang Yuan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study
- (2016) Ralph Salloum et al. JOURNAL OF NEURO-ONCOLOGY
- Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas
- (2016) Xing Fan et al. JOURNAL OF NEURO-ONCOLOGY
- TERT Genetic Mutations as Prognostic Marker in Glioma
- (2016) Peiliang Geng et al. MOLECULAR NEUROBIOLOGY
- HumanTERTpromoter mutation enables survival advantage fromMGMTpromoter methylation inIDH1wild-type primary glioblastoma treated by standard chemoradiotherapy
- (2016) HuyTram N. Nguyen et al. NEURO-ONCOLOGY
- Classification based on mutations ofTERTpromoter andIDHcharacterizes subtypes in grade II/III gliomas
- (2016) Pei Yang et al. NEURO-ONCOLOGY
- Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma
- (2016) Nozomi Matsumura et al. NEUROPATHOLOGY
- A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
- (2016) Hideyuki Arita et al. Acta Neuropathologica Communications
- Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
- (2015) Felix Sahm et al. ACTA NEUROPATHOLOGICA
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas-Same Entity or First Cousins?
- (2015) Sanda Alexandrescu et al. BRAIN PATHOLOGY
- Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma
- (2015) Ji Eun Oh et al. BRAIN PATHOLOGY
- Neurocognitive functions and health-related quality of life in glioblastoma patients: a concise review of the literature
- (2015) E. Bergo et al. EUROPEAN JOURNAL OF CANCER CARE
- Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis
- (2015) Sabine Spiegl-Kreinecker et al. NEURO-ONCOLOGY
- Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
- (2015) Marina N. Nikiforova et al. NEURO-ONCOLOGY
- Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
- (2015) Gabriela M. Baerlocher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
- (2015) Ke Gao et al. Oncotarget
- TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
- (2015) Mohamed Ali Mosrati et al. Oncotarget
- TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
- (2015) Barbara Heidenreich et al. Oncotarget
- Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas
- (2015) Patrick J. Killela et al. Oncotarget
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Stupp et al. ANNALS OF ONCOLOGY
- Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas
- (2014) Kathleen Dorris et al. JOURNAL OF NEURO-ONCOLOGY
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
- (2014) Matthias Simon et al. NEURO-ONCOLOGY
- Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes
- (2014) M. Labussiere et al. NEUROLOGY
- TERT Promoter Mutations Lead to High Transcriptional Activity under Hypoxia and Temozolomide Treatment and Predict Poor Prognosis in Gliomas
- (2014) Chen Chen et al. PLoS One
- Eribulin Mesylate Targets Human Telomerase Reverse Transcriptase in Ovarian Cancer Cells
- (2014) Satoko Yamaguchi et al. PLoS One
- TERT promoter mutations in primary and secondary glioblastomas
- (2013) Naosuke Nonoguchi et al. ACTA NEUROPATHOLOGICA
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
- (2013) Bette Kay Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
- (2013) Pedro Castelo-Branco et al. LANCET ONCOLOGY
- Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma
- (2013) A. Broniscer et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine
- (2013) Olivier Adotévi et al. Human Vaccines & Immunotherapeutics
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner
- (2010) Martin J. Law et al. CELL
- The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
- (2010) C. O. Marian et al. CLINICAL CANCER RESEARCH
- Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
- (2010) Barbara S. Paugh et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Giant cell glioblastoma: A glioblastoma subtype with distinct epidemiology and superior prognosis
- (2009) Kevin R. Kozak et al. NEURO-ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- How Telomeres Solve the End-Protection Problem
- (2009) T. de Lange SCIENCE
- B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells
- (2008) Yu Yao et al. JOURNAL OF NEURO-ONCOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search